TECK:NYSETeck Resources Ltd Analysis
Data as of 2026-06-14 - not real-time
$64.84
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Teck Resources is trading just above its 20‑day and 50‑day moving averages, indicating a short‑term bullish bias, while the 200‑day SMA remains well below the current price, underscoring a longer‑term uptrend. Momentum indicators are mixed: the RSI hovers in the mid‑50s, suggesting neither overbought nor oversold conditions, whereas the MACD shows a bearish histogram, hinting at potential downside pressure. Fundamentally, the company posted a robust revenue surge of roughly 72% YoY and a sharp EPS improvement in Q1, reflecting strong operational performance in its copper and zinc segments. However, the balance sheet reveals a high debt load relative to equity and cash, raising concerns about financial flexibility. The dividend yield is modest at about half a percent but the payout ratio is low, supporting dividend sustainability. Volatility is elevated, with a 30‑day range exceeding 50% and a beta well above market, flagging heightened price swings. Analyst consensus remains neutral, with a “hold” recommendation and target prices below the current market level, indicating perceived overvaluation. The sector’s cyclical nature and exposure to commodity price swings add to the risk profile. Overall, the stock presents a blend of solid growth fundamentals tempered by financial and market volatility, suggesting a cautious stance for investors.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price above short‑term moving averages
- Bearish MACD histogram signals caution
- High short‑term volatility
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Strong revenue and EPS growth
- Elevated debt relative to cash
- Analyst target prices below current level
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- Long‑term demand for copper and zinc
- Sustainable dividend with low payout ratio
- Potential upside if commodity cycle strengthens
Key Metrics & Analysis
Financial Health
Revenue Growth72.20%
Profit Margin14.91%
P/E Ratio24.0
ROE5.92%
Debt/Equity36.94
P/B Ratio1.7
Technical Analysis
TrendBullish
RSI54.0
Support$58.50
Resistance$71.25
MA 20$63.87
MA 50$60.94
MA 200$50.29
MACDBearish
VolumeStable
Fear & Greed Index89.86
Valuation
Target Price$47.84
Upside/Downside-26.21%
GradeFair
TypeGrowth
Dividend Yield0.56%
Risk Assessment
Beta2.13
Volatility56.10%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.